Brian Wynne Selected Research

Respiratory Tract Infections (Respiratory Tract Infection)

1/2004	Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
10/2002	Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian Wynne Research Topics

Disease

14	Infections 03/2023 - 10/2002
3	Pneumonia (Pneumonitis) 02/2005 - 10/2002
3	Chronic Bronchitis 01/2005 - 10/2002
2	HIV Infections (HIV Infection) 01/2018 - 01/2014
2	Headache (Headaches) 01/2018 - 12/2017
2	Dizziness (Lightheadedness) 11/2014 - 11/2013
2	Otitis Media 06/2005 - 01/2004
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2004 - 10/2002
2	Sinusitis 01/2004 - 10/2002
1	Viremia 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2023
1	Inflammation (Inflammations) 01/2022
1	Atherosclerosis 01/2022
1	Weight Gain 01/2021
1	Insulin Resistance 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Osteoporosis 01/2018
1	Nasopharyngitis 01/2018
1	Nausea 12/2017
1	Chronic Hepatitis C 01/2016
1	Cellulitis 11/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Exanthema (Rash) 11/2013
1	Sleepiness 11/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Rhinosinusitis 08/2006

Drug/Important Bio-Agent (IBA)

13	dolutegravirIBA 03/2023 - 11/2013
6	Amoxicillin (Wymox)FDA LinkGeneric 08/2006 - 10/2002
6	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 08/2006 - 10/2002
5	Lamivudine (Epivir)FDA Link 01/2022 - 12/2017
4	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 08/2006 - 10/2002
3	NucleosidesIBA 11/2023 - 01/2022
3	IntegrasesIBA 11/2023 - 01/2016
3	Reverse Transcriptase InhibitorsIBA 11/2023 - 01/2022
3	Integrase InhibitorsIBA 03/2023 - 11/2013
3	Emtricitabine (Emtriva)FDA Link 12/2021 - 12/2017
3	RNA (Ribonucleic Acid)IBA 12/2021 - 11/2013
3	Tenofovir (Viread)FDA Link 12/2019 - 12/2017
3	beta-Lactamases (beta-Lactamase)IBA 08/2006 - 10/2002
3	Penicillins (Penicillin)FDA Link 08/2006 - 10/2002
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
2	rilpivirine drug combination dolutegravirIBA 01/2022 - 01/2018
2	Rilpivirine (TMC-278)IBA 01/2022 - 01/2018
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2021 - 11/2013
2	TabletsIBA 01/2018 - 01/2004
2	lamivudine drug combination abacavir FDA Link 12/2015 - 11/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	FumaratesIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	LipidsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Ritonavir (Norvir)FDA Link 12/2017
1	Atazanavir Sulfate (Reyataz)FDA Link 12/2017
1	abacavir (Ziagen)FDA Link 12/2017
1	Organic Cation Transporter 2IBA 01/2016
1	daclatasvirIBA 01/2016
1	CreatinineIBA 11/2014
1	Alanine Transaminase (SGPT)IBA 11/2014
1	HIV IntegraseIBA 01/2014
1	Metformin (Glucophage)FDA LinkGeneric 01/2014
1	RacivirIBA 11/2013
1	PlasticsIBA 01/2013
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2005
1	Anti-Infective Agents (Microbicides)IBA 01/2004
1	Dosage Forms (Dosage Form)IBA 01/2004
1	Clarithromycin (Biaxin)FDA LinkGeneric 10/2002
1	Levofloxacin (Levaquin)FDA Link 10/2002

Therapy/Procedure

7	Therapeutics 03/2023 - 08/2006
1	Art Therapy 01/2018